Estrella Immunopharma (ESLAW) Q2 2025 Earnings

May 14Confirmed
Q4 2024
Q1 2025
Q2 2025
-0.12
-0.12
-0.11
-0.11

Details

Expected EPS
-0.11
Actual EPS
-0.11
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Estrella Immunopharma⁩ (⁦ESLAW⁩) has reported earnings of ⁦-0.11⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts